Trial intelligence / Profile preview

Tranexamic acid dosing in pediatric cardiac surgery

2010-018301-11Phase 2

Sponsor
Hôpital Marie-Lannelongue
Start
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of tranexamic acid in Cardiovascular Malformation (CVM), sponsored by Hôpital Marie-Lannelongue.

02

Drugs

tranexamic acid
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on 2010-018301-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-018301-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call